Study finds rapamycin shows greatest longevity effect in 20-year NIH Interventions Testing Program The first comprehensive review of two decades of research from the National Institute on Aging’s Interventions Testing Program highlights 13 interventions that show promise in preclinical studies for significantly extending lifespan and improving healthspan. Aging is the major risk factor for […]
Share This Story
FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]
Share This Story
A cancer diagnosis is always devastating and is especially overwhelming when the patient is a child. This is why the CURE Childhood Cancer Foundation is on a mission to advance research that will bring an end to childhood cancers. Recently, Raushan Kurmasheva, PhD, assistant professor at the Greehey Children’s Cancer Research Institute and Department of […]
Share This Story
Yahoo! Finance: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Share This Story
Nasdaq: Plus Therapeutics Initiates ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases Treatment
Share This Story
Benzinga: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Share This Story
Morningstar: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Share This Story
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]
Share This Story
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career investigators. Voelcker Fund Young Investigator Awards The Voelcker Fund Young Investigator Award will fund each recipient’s […]
Share This Story
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment. This study analyzed utDNA from patients in the SWOG S1605 trial, who were treated with atezolizumab, an immunotherapy drug. Researchers used the UroAmp test to examine […]
Share This Story